Schizophrenia trials recruiting in Maryland

All Schizophrenia trials nationally

Cities in Maryland

Recruiting trials in Maryland

• 52-week Open Label Safety-Tolerability Study
  NCT07369154 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Gaithersburg
• A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
  NCT07459647 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Gaithersburg
• A Study of Brenipatide in Adult Participants With Schizophrenia
  NCT07410507 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Maryland: Gaithersburg
• A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
  NCT07734493 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Maryland: Gaithersburg
• A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
  NCT07145918 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Gaithersburg
• A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
  NCT07191483 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Maryland: Gaithersburg
• A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
  NCT06894212 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Gaithersburg
• CBT-CP for Veterans With SMI
  NCT06758414 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
  NCT05208190 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Baltimore
• Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
  NCT07101094 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore, Bel Air, Catonsville
• Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
  NCT07184619 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
  NCT06963034 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Gaithersburg
• NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
  NCT07114874 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Gaithersburg
• Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
  NCT07686263 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Gaithersburg
• Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
  NCT05184335 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Gaithersburg
• Study of ALTO-101 in Patients With Schizophrenia
  NCT06502964 · Phase: Phase 2 · Ages: 21 Years to 55 Years · Sex: All (male and female) · Maryland: Gaithersburg
• Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
  NCT07565428 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Maryland: Gaithersburg
• Synbiotic Compound to Reduce Symptoms of Schizophrenia
  NCT04226898 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Batlimore
• TMS for Inhibition Enhancement in Schizophrenia
  NCT06155682 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · Maryland: Catonsville
• Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
  NCT05440214 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• White Matter Plasticity in Schizophrenia
  NCT06641297 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 45 Years · Sex: All (male and female) · Maryland: Catonsville